World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
29925
World Ranking
14504
National Ranking
768

Overview

Andreas Wollenberg is affiliated with Ludwig-Maximilians-Universität München in Germany. Their research primarily focuses on the field of Medicine, with specific contributions to Dermatology, Immunology and Allergy, Physiology, Rheumatology, and Immunology as subfields of study.

Their work centers on topics such as Dermatology and Skin Diseases, Allergic Rhinitis and Sensitization, Asthma and respiratory diseases, Food Allergy and Anaphylaxis Research, Urticaria and Related Conditions, Contact Dermatitis and Allergies, and Transgenic Plants and Applications.

Wollenberg has published extensively in several prominent journals. Frequent publication venues include:

  • Journal of the European Academy of Dermatology and Venereology
  • British Journal of Dermatology
  • JDDG Journal der Deutschen Dermatologischen Gesellschaft
  • Journal of the American Academy of Dermatology
  • SKIN The Journal of Cutaneous Medicine

Recent papers authored by Wollenberg demonstrate involvement in clinical dermatology and immunological research. Selected publications include:

  • Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2), 2020, British Journal of Dermatology
  • ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children, 2020, Journal of the European Academy of Dermatology and Venereology

Frequent co-authors include:

  • Eric L. Simpson
  • Jonathan I. Silverberg
  • Thomas Werfel
  • Amy S. Paller
  • Jacob P. Thyssen

Wollenberg's research collaborations and publication record reflect a focus on clinical trials and position papers related to atopic dermatitis and other dermatological conditions. Their expert contributions pertain to both adult and pediatric patient populations within these areas.

Best Publications

  • Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

    Eric L. Simpson;Thomas Bieber;Emma Guttman-Yassky;Lisa A. Beck

  • Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I.

    A Wollenberg;S Barbarot;T Bieber;S Christen-Zaech

  • Guidelines for treatment of atopic eczema (atopic dermatitis) part I.

    J. Ring;A. Alomar;T. Bieber;M. Deleuran

  • Anti-interleukin-31 receptor a antibody for atopic dermatitis

    Thomas Ruzicka;Jon M. Hanifin;Masutaka Furue;Grazyna Pulka

  • Cellular and molecular immunologic mechanisms in patients with atopic dermatitis

    Thomas Werfel;Jean-Pierre Allam;Tilo Biedermann;Kilian Eyerich

  • Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*

    A. Wollenberg;A. Blauvelt;E. Guttman‐Yassky;M. Worm

  • Plasmacytoid Dendritic Cells: A New Cutaneous Dendritic Cell Subset with Distinct Role in Inflammatory Skin Diseases

    Andreas Wollenberg;Moritz Wagner;Sandra Günther;Andreas Towarowski

  • Immunomorphological and Ultrastructural Characterization of Langerhans Cells and a Novel, Inflammatory Dendritic Epidermal Cell (IDEC) Population in Lesional Skin of Atopic Eczema

    Andreas Wollenberg;Stefan Kraft;Daniel Hanau;Thomas Bieber

  • Safety and Efficacy of 1 Year of Tacrolimus Ointment Monotherapy in Adults With Atopic Dermatitis

    Sakari Reitamo;Andreas Wollenberg;Erwin Schöpf;Jean Luc Perrot

  • ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients.

    A. Wollenberg;Arnold Oranje;M. Deleuran;D. Simon

  • Treatment of atopic dermatitis with tralokinumab, an anti-IL-13 mAb.

    Andreas Wollenberg;Michael D. Howell;Emma Guttman-Yassky;Jonathan I. Silverberg

  • Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.

    Eric L Simpson;Rodney Sinclair;Seth Forman;Andreas Wollenberg

  • ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis

    U. Darsow;A. Wollenberg;D. Simon;A. Taïeb

  • Conjunctivitis in dupilumab clinical trials.

    B. Akinlade;E. Guttman-Yassky;M. de Bruin-Weller;E. L. Simpson

  • Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials

    Eric L. Simpson;J.‐P. Lacour;L. Spelman;R. Galimberti

  • Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment

    Cornelia Tillack;Laura Maximiliane Ehmann;Matthias Friedrich;Ruediger P. Laubender

  • Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 cases.

    Andreas Wollenberg;Claudia Zoch;Stefanie Wetzel;Gerd Plewig

  • Viral infections in atopic dermatitis: pathogenic aspects and clinical management.

    Andreas Wollenberg;Stefanie Wetzel;Walter H.C Burgdorf;Jürgen Haas

  • Cathelicidin deficiency predisposes to eczema herpeticum.

    Michael D. Howell;Andreas Wollenberg;Richard L. Gallo;Michael Flaig

  • Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis.

    Sakari Reitamo;Malcolm Rustin;Thomas Ruzicka;Frédéric Cambazard

Frequent Co-Authors

Thomas Bieber
Thomas Bieber University of Bonn
Thomas Werfel
Thomas Werfel Hannover Medical School
Eric L. Simpson
Eric L. Simpson Oregon Health & Science University
Thomas Ruzicka
Thomas Ruzicka Ludwig-Maximilians-Universität München
Margitta Worm
Margitta Worm Charité - University Medicine Berlin
Jacob P. Thyssen
Jacob P. Thyssen University of Copenhagen
Emma Guttman-Yassky
Emma Guttman-Yassky Icahn School of Medicine at Mount Sinai
Jonathan I. Silverberg
Jonathan I. Silverberg George Washington University Hospital
Ulf Darsow
Ulf Darsow Technical University of Munich
Dagmar Simon
Dagmar Simon University of Bern

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways in healthcare is increasingly popular, especially with the flexibility offered by online education. For those looking to advance clinical expertise, pursuing one of the cheapest dnp programs can be a smart way to earn a Doctor of Nursing Practice degree without a significant financial burden.

If a career in pharmaceuticals excites you, consider an accredited pharmacy school online accredited program. These programs offer flexibility and recognized credentials, preparing graduates for various roles in pharmacy.

For those interested in healthcare data and patient information systems, a him bachelor's degree online provides a direct route into the growing field of health information management.

Additionally, many students are turning to medical coding certification to quickly enter the healthcare workforce by mastering the essential language of billing and coding.

Each of these online degree and certification options opens doors to rewarding healthcare careers and can serve as a foundation for further medical studies in the USA.

Best Scientists Citing Andreas Wollenberg

Trending Scientists

Recently Published Articles